NASDAQ:PDEX Pro-Dex (PDEX) Stock Price, News & Analysis $18.79 -0.29 (-1.52%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$18.72▼$19.4350-Day Range$17.13▼$19.9052-Week Range$14.51▼$22.99Volume1,813 shsAverage Volume7,442 shsMarket Capitalization$64.26 millionP/E Ratio32.40Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Pro-Dex alerts: Email Address Pro-Dex MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.49% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.22Based on 3 Articles This WeekInsider TradingSelling Shares$47,306 Sold Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.88 out of 5 starsMedical Sector842nd out of 936 stocksSurgical & Medical Instruments Industry91st out of 101 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Pro-Dex.Read more about Pro-Dex's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.49% of the float of Pro-Dex has been sold short.Short Interest Ratio / Days to CoverPro-Dex has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Pro-Dex has recently increased by 122.00%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldPro-Dex does not currently pay a dividend.Dividend GrowthPro-Dex does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PDEX. Previous Next 1.8 News and Social Media Coverage News SentimentPro-Dex has a news sentiment score of 0.22. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Pro-Dex this week, compared to 0 articles on an average week. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Pro-Dex insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $47,306.00 in company stock.Percentage Held by Insiders42.60% of the stock of Pro-Dex is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 15.28% of the stock of Pro-Dex is held by institutions.Read more about Pro-Dex's insider trading history. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Pro-Dex is 32.40, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 140.44.Price to Earnings Ratio vs. SectorThe P/E ratio of Pro-Dex is 32.40, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 148.37.Price to Book Value per Share RatioPro-Dex has a P/B Ratio of 2.11. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Pro-Dex's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED will cut rates any day now. But there's one indicator that's flashing a BIG warning sign to investors.Take these 4 steps to protect your retirement here. About Pro-Dex Stock (NASDAQ:PDEX)Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.Read More PDEX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PDEX Stock News HeadlinesJune 27, 2024 | insidertrades.comPro-Dex, Inc. (NASDAQ:PDEX) Director Angelita Rebamontan Domingo Sells 2,585 SharesJuly 22, 2024 | americanbankingnews.comComparing Spectral AI (NASDAQ:MDAI) & Pro-Dex (NASDAQ:PDEX)July 26, 2024 | Behind the Markets (Ad)Rare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED will cut rates any day now. But there's one indicator that's flashing a BIG warning sign to investors.May 21, 2024 | finance.yahoo.comPro-Dex, Inc. (PDEX)May 3, 2024 | investorplace.comPDEX Stock Earnings: Pro-Dex Misses EPS, Beats Revenue for Q3 2024April 26, 2024 | msn.comHow to use Samsung Dex for gamingApril 23, 2024 | msn.comWhat is Samsung DeX and how does it work?April 19, 2024 | money.usnews.comPro-Dex Inc. (co)July 26, 2024 | Behind the Markets (Ad)Rare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED will cut rates any day now. But there's one indicator that's flashing a BIG warning sign to investors.April 9, 2024 | msn.comAutoPro X accessory will bring Samsung DeX to your vehicleApril 2, 2024 | benzinga.comVicarious Surgical Stock (NYSE:RBOT), Quotes and News SummaryMarch 15, 2024 | seekingalpha.comMonogram Orthopaedics reports FY resultsFebruary 22, 2024 | finance.yahoo.comThe Returns On Capital At Pro-Dex (NASDAQ:PDEX) Don't Inspire ConfidenceFebruary 8, 2024 | finance.yahoo.comPro-Dex, Inc. Announces Fiscal 2024 Second Quarter and Six-Month ResultsJanuary 26, 2024 | finance.yahoo.comPro-Dex (NASDAQ:PDEX) shareholders have earned a 7.2% CAGR over the last five yearsDecember 30, 2023 | finance.yahoo.comIs Pro-Dex, Inc.'s (NASDAQ:PDEX) Latest Stock Performance A Reflection Of Its Financial Health?November 14, 2023 | finance.yahoo.comHere’s Why You Should Consider Buying Pro-Dex (PDEX) SharesNovember 10, 2023 | morningstar.comPro-Dex Inc PDEXSee More Headlines Receive PDEX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/02/2024Today7/26/2024Next Earnings (Estimated)10/11/2024Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:PDEX CUSIPN/A CIK788920 Webwww.pro-dex.com Phone(949) 769-3200Fax949-769-3281Employees140Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.58 Trailing P/E Ratio32.90 Forward P/E RatioN/A P/E GrowthN/ANet Income$7.07 million Net Margins4.13% Pretax Margin5.50% Return on Equity6.50% Return on Assets4.01% Debt Debt-to-Equity Ratio0.25 Current Ratio3.45 Quick Ratio2.08 Sales & Book Value Annual Sales$46.09 million Price / Sales1.42 Cash Flow$2.22 per share Price / Cash Flow8.58 Book Value$8.91 per share Price / Book2.14Miscellaneous Outstanding Shares3,420,000Free Float1,963,000Market Cap$65.25 million OptionableNot Optionable Beta0.37 The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Richard Lee Van Kirk Jr. (Age 63)CEO, President, COO & Director Comp: $418.61kMs. Alisha K. Charlton (Age 54)CFO & Corporate Secretary Comp: $297.61kKey CompetitorsNeuroneticsNASDAQ:STIMT2 BiosystemsNASDAQ:TTOOBeyond AirNASDAQ:XAIRLyra TherapeuticsNASDAQ:LYRAPAVmedNASDAQ:PAVMView All CompetitorsInsiders & InstitutionsAngelita Rebamontan DomingoSold 2,585 sharesTotal: $47,305.50 ($18.30/share)Perritt Capital Management Inc.Bought 1,813 shares on 5/15/2024Ownership: 0.175%LSV Asset ManagementSold 3,099 shares on 5/6/2024Ownership: 0.666%View All Insider TransactionsView All Institutional Transactions PDEX Stock Analysis - Frequently Asked Questions How have PDEX shares performed this year? Pro-Dex's stock was trading at $17.52 at the beginning of 2024. Since then, PDEX shares have increased by 7.2% and is now trading at $18.79. View the best growth stocks for 2024 here. How were Pro-Dex's earnings last quarter? Pro-Dex, Inc. (NASDAQ:PDEX) posted its quarterly earnings data on Thursday, May, 2nd. The medical instruments supplier reported $0.19 EPS for the quarter. The medical instruments supplier earned $14.29 million during the quarter. Pro-Dex had a net margin of 4.13% and a trailing twelve-month return on equity of 6.50%. What is Michael J. Berthelot's approval rating as Pro-Dex's CEO? 3 employees have rated Pro-Dex Chief Executive Officer Michael J. Berthelot on Glassdoor.com. Michael J. Berthelot has an approval rating of 85% among the company's employees. How do I buy shares of Pro-Dex? Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Pro-Dex own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pro-Dex investors own include KEMET (KEM), NVIDIA (NVDA), Enterprise Products Partners (EPD), Micron Technology (MU), AT&T (T), AbbVie (ABBV) and Alibaba Group (BABA). This page (NASDAQ:PDEX) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro-Dex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pro-Dex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.